Brain Tumor News!

Note: The comments under each article title are the opinion of our president, Al Musella, DPM,
and do not reflect official policy of the Musella Foundation!

12/11/08 21st Century Brain Surgery: Minimally Invasive Endonasal Approach, Experienced Surgeons Give Patients the Advantages They Need        

12/10/08 Gliadel (BCNU) wafer plus concomitant temozolomide therapy after primary resection of glioblastoma multiforme.        

12/08/08 Non-Malignant Patient and Caregiver Support Group followed by Special Guest Speaker Dr. Patrick J. Kelly        

12/05/08 Drug slows brain cancer, Calgary researchers say        

12/04/08 Ranbaxy in pact to market BioPro's brain tumour drug (Gliadel) in India news        

11/26/08 Final Data From Phase 1 Investigator-Sponsored Trial of Oncophage® Cancer Vaccine in Glioma Presented at the Society for Neuro-Oncology’s Annual Meeting        

11/26/08 RTOG Reports That Chemotherapy Added to Radiotherapy Improves Survival (For low grade gliomas)        

11/26/08 The National Brain Tumor Society is hosting our 12th annual teleconference on December 2, 2008        

11/25/08 STUDIES SHOW NOVEL DEVICE MAY ENHANCE CHEMOTHERAPY TREATMENT IN BRAIN TUMORS        

11/25/08 Free Teleconference on Latest Glioma Treatments: A Program for Patients and Families Presented by: Dr. Howard Fine        

11/25/08 Brain-cancer center at Swedish maps tumors to design treatment        

11/23/08 A multi-institutional phase II study on second-line Fotemustine chemotherapy in recurrent glioblastoma.        

11/21/08 Florida Brain Tumor Association annual brain tumor conference.        

11/19/08 Phase I/II Trial Erlotinib and Temozolomide With Radiation Therapy in the Treatment of Newly Diagnosed Glioblastoma Multiforme: North Central Cancer Treatment Group Study N0177.        

11/19/08 Randomized Phase II Study of Cilengitide, an Integrin-Targeting Arginine-Glycine-Aspartic Acid Peptide, in Recurrent Glioblastoma Multiforme.        

11/19/08 Pediatric glioblastomas: A histopathological and molecular genetic study.        

11/19/08 Safety profile of carmustine wafers in malignant glioma: a review of controlled trials and a decade of clinical experience.        

11/19/08 Efficacy, safety and patterns of response and recurrence in patients with recurrent high-grade gliomas treated with bevacizumab (Avastin) plus irinotecan (CPT-11).        

11/19/08 LabCorp developing new brain cancer test        

---

Displaying Stories 3341 to 3360 of 7673
Previous 20           Next 20